Ser290
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser290  -  RRAD (human)

Site Information
GRIVARNsRKMAFRA   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 457397

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 )
Disease tissue studied:
breast cancer ( 1 ) , breast cancer, triple negative ( 1 )
Relevant cell line - cell type - tissue:
breast ( 1 )

Upstream Regulation
Kinases, in vitro:
CK2A1 (human) ( 2 ) , PKCA (human) ( 2 )

Downstream Regulation
Effects of modification on RRAD:
molecular association, regulation ( 2 )
Induce interaction with:
Calmodulin (human) ( 2 )

References 

1

Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704
24719451   Curated Info

2

Moyers JS, Zhu J, Kahn CR (1998) Effects of phosphorylation on function of the Rad GTPase. Biochem J 333 ( Pt 3), 609-14
9677319   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.